Core Laboratories (CLB) Misses Q1 EPS by 29c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $9.91 +5.43%
Financial Fact:
Interest expense: 2.57M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Interest expense: 2.57M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.00, $0.29 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $123.6 million versus the consensus estimate of $143.5 million.
GUIDANCE:
Core Laboratories sees Q2 2025 revenue of $128-134 million, versus the consensus of $128.9 million.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kotak Upgrades Indusind Bank Ltd (IIB:IN) to Reduce (3)
- Kotak Upgrades Torrent Pharma (TRP:IN) to Buy (1)
- JPMorgan Upgrades Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) to Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
